• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证新提出的世界卫生组织结膜黑色素细胞上皮内病变分类系统:与 C-MIN 和 PAM 分类方案的比较。

Validation of the Newly Proposed World Health Organization Classification System for Conjunctival Melanocytic Intraepithelial Lesions: A Comparison with the C-MIN and PAM Classification Schemes.

机构信息

Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Department of Ophthalmology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Ocular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Am J Ophthalmol. 2021 Mar;223:60-74. doi: 10.1016/j.ajo.2020.10.020. Epub 2020 Oct 30.

DOI:10.1016/j.ajo.2020.10.020
PMID:33130046
Abstract

PURPOSE

We sought to compare the sensitivity, specificity, accuracy, and interobserver agreement of the two most commonly used classification systems for conjunctival melanocytic intraepithelial lesions with the new World Health Organization (WHO) classification.

DESIGN

Retrospective case series and evaluation of classification systems.

METHODS

We reviewed the pathology and medical records of all patients who underwent a primary biopsy procedure for conjunctival primary acquired melanosis (PAM) at Wills Eye Hospital between 1974 and 2002 who had ≥36 months of follow-up. Data collected included age, sex, clinical findings, recurrence, and progression to melanoma. Twelve ophthalmic pathologists analyzed scanned hematoxylin and eosin-stained virtual microscopic slides using 3 classification systems: PAM, conjunctival melanocytic intraepithelial neoplasia, and the WHO 4th edition classification of conjunctival melanocytic intraepithelial lesions. Observer agreement, sensitivity, specificity, and diagnostic accuracy of each classification system were assessed.

RESULTS

There were 64 patients who underwent 83 primary excisions with cryotherapy for conjunctival PAM who had adequate tissue for histopathologic evaluation. The interobserver agreement in distinction between the low- and high-grade lesions was 76% for PAM, 67% for conjunctival melanocytic intraepithelial neoplasia, and 81% for WHO classification system. Low-grade lesions provided the greatest interpretative challenge with all 3 classification systems. The 3 classification systems had comparable accuracy of 81%-83% in their ability to identify lesions with potential for recurrence.

CONCLUSIONS

This study highlights the comparable strengths and limitations of the 3 classification systems for conjunctival melanocytic intraepithelial lesions and suggests that the simplified WHO classification scheme is appropriate for evaluation of these lesions.

摘要

目的

我们旨在比较两种最常用于结膜黑色素上皮内病变的分类系统与新的世界卫生组织(WHO)分类法的敏感性、特异性、准确性和观察者间一致性。

设计

回顾性病例系列和分类系统评估。

方法

我们回顾了 1974 年至 2002 年间在威尔斯眼科医院接受结膜原发性获得性黑色素沉着症(PAM)初次活检的所有患者的病理学和病历,这些患者有≥36 个月的随访。收集的数据包括年龄、性别、临床发现、复发和进展为黑色素瘤。12 位眼科病理学家使用 3 种分类系统分析了扫描的苏木精和伊红染色虚拟显微镜载玻片:PAM、结膜黑色素上皮内瘤和 WHO 第 4 版结膜黑色素上皮内病变分类。评估了每种分类系统的观察者间一致性、敏感性、特异性和诊断准确性。

结果

共有 64 名患者接受了 83 例冷冻治疗原发性结膜 PAM 切除术,这些患者有足够的组织进行组织病理学评估。在区分低级别和高级别病变方面,PAM 的观察者间一致性为 76%,结膜黑色素上皮内瘤为 67%,WHO 分类系统为 81%。所有 3 种分类系统中,低级别病变的解释最具挑战性。在识别具有复发潜力的病变方面,这 3 种分类系统的准确性相当,均为 81%-83%。

结论

本研究强调了结膜黑色素上皮内病变的 3 种分类系统的可比性和局限性,并表明简化的 WHO 分类方案适用于这些病变的评估。

相似文献

1
Validation of the Newly Proposed World Health Organization Classification System for Conjunctival Melanocytic Intraepithelial Lesions: A Comparison with the C-MIN and PAM Classification Schemes.验证新提出的世界卫生组织结膜黑色素细胞上皮内病变分类系统:与 C-MIN 和 PAM 分类方案的比较。
Am J Ophthalmol. 2021 Mar;223:60-74. doi: 10.1016/j.ajo.2020.10.020. Epub 2020 Oct 30.
2
A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance.一项多中心研究验证了 WHO 2022 年分类在结膜黑色素细胞上皮内病变中的临床和预后相关性。
Lab Invest. 2024 Jan;104(1):100281. doi: 10.1016/j.labinv.2023.100281. Epub 2023 Nov 3.
3
Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16.结膜黑色素细胞上皮内病变的免疫组织化学特征分析,包括 SOX10、HMB45、Ki67 和 P16。
Am J Ophthalmol. 2021 Feb;222:148-156. doi: 10.1016/j.ajo.2020.09.033. Epub 2020 Sep 28.
4
[Focus on clinical and pathological management of conjunctival melanocytic tumors].[聚焦结膜黑素细胞肿瘤的临床与病理管理]
Ann Pathol. 2018 Jun;38(3):153-163. doi: 10.1016/j.annpat.2018.03.006. Epub 2018 May 24.
5
Conjunctival Melanocytic Lesions.结膜黑素细胞病变
Arch Pathol Lab Med. 2022 May 1;146(5):632-646. doi: 10.5858/arpa.2021-0006-RA.
6
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.葡萄膜和结膜黑色素瘤以及良性和癌前结膜黑素细胞病变中TERT启动子突变的患病率及其影响
Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30. doi: 10.1167/iovs.14-14901.
7
Differential immunoreactivity of melanocytic lesions of the conjunctiva.结膜黑素细胞病变的免疫反应性差异
Histopathology. 2001 Oct;39(4):426-31. doi: 10.1046/j.1365-2559.2001.01168.x.
8
Finding of conjunctival melanocytic pigmented lesions within pterygium.在翼状胬肉内发现结膜黑素细胞色素沉着性病变。
Histopathology. 2006 Mar;48(4):387-93. doi: 10.1111/j.1365-2559.2006.02346.x.
9
PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.结膜交界性黑色素细胞增生中 PRAME 的表达:原发性获得性黑色素沉着症/结膜黑色素细胞上皮内病变的潜在生物标志物。
Am J Dermatopathol. 2022 Oct 1;44(10):734-740. doi: 10.1097/DAD.0000000000002201. Epub 2022 Apr 11.
10
Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?结膜原发性获得性黑素沉着症:是时候采用新术语了吗?
Am J Ophthalmol. 2016 Feb;162:3-19.e1. doi: 10.1016/j.ajo.2015.11.003. Epub 2015 Nov 10.

引用本文的文献

1
Conjunctival melanoma: comprehensive insights into clinical features, genetic alterations, and modern treatment approaches.结膜黑色素瘤:对临床特征、基因改变及现代治疗方法的全面见解
Pathol Oncol Res. 2025 Aug 4;31:1612085. doi: 10.3389/pore.2025.1612085. eCollection 2025.
2
Conjunctival Melanoma: A Clinical Review and Update.结膜黑色素瘤:临床综述与更新
Cancers (Basel). 2024 Sep 10;16(18):3121. doi: 10.3390/cancers16183121.
3
Dendritic Melanocytic Hyperplasia in Pterygia: A Potential Source of Diagnostic Confusion with Primary Acquired Melanosis.
翼状胬肉中的树突状黑素细胞增生:与原发性后天性黑素沉着症诊断混淆的潜在来源。
Ocul Oncol Pathol. 2023 Aug;9(1-2):48-55. doi: 10.1159/000530514. Epub 2023 Apr 7.
4
A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance.一项多中心研究验证了 WHO 2022 年分类在结膜黑色素细胞上皮内病变中的临床和预后相关性。
Lab Invest. 2024 Jan;104(1):100281. doi: 10.1016/j.labinv.2023.100281. Epub 2023 Nov 3.
5
The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit.《世界卫生组织眼与眼眶肿瘤分类》第5版
Ocul Oncol Pathol. 2023 Sep;9(3-4):71-95. doi: 10.1159/000530730. Epub 2023 Apr 18.
6
Factors affecting recurrence and metastasis in conjunctival melanoma.影响结膜黑色素瘤复发和转移的因素。
Int Ophthalmol. 2023 Nov;43(11):4203-4215. doi: 10.1007/s10792-023-02830-y. Epub 2023 Aug 28.
7
Conjunctival amelanotic melanoma presenting as a multifocal pink lesion.表现为多灶性粉红色病变的结膜无黑色素性黑色素瘤。
BMJ Case Rep. 2022 Dec 7;15(12):e250682. doi: 10.1136/bcr-2022-250682.
8
Bone metastasis in a case of primary acquired melanosis with atypia resulting from conjunctiva melanoma.结膜黑色素瘤导致的原发性获得性非典型性黑素沉着症伴骨转移1例。
Am J Ophthalmol Case Rep. 2022 Oct 21;29:101730. doi: 10.1016/j.ajoc.2022.101730. eCollection 2023 Mar.
9
Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.眼色素层黑色素瘤瘤旁应用干扰素 α2b 和丝裂霉素的真实世界数据。
Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):1159-1166. doi: 10.1007/s00417-022-05832-1. Epub 2022 Oct 18.